Moscow, Russia

Alexei Kayushin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: St Pharm Co., Ltd.. Active years: 2014.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Alexei Kayushin in Nucleotide Oligomer Preparation

Introduction

Alexei Kayushin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of nucleotide chemistry, particularly in the preparation of nucleotide oligomers. His innovative methods have the potential to enhance the efficiency and purity of nucleotide synthesis.

Latest Patents

Kayushin holds a patent for the "Preparation of nucleotide oligomer." This invention provides a method for preparing nucleotide oligomers that includes several key steps. The process involves coupling a nucleotide dimer or trimer to a nucleoside attached to solid supports. Following this, nucleotide monomers are sequentially coupled to create the nucleotide oligomer. Finally, the nucleotide oligomers are removed from the solid supports. This method results in nucleotide oligomers that have 15-20% higher purity compared to conventional methods. It enables the efficient and cost-effective synthesis of high-purity nucleotide oligomers in a shorter timeframe.

Career Highlights

Kayushin is associated with St Pharm Co., Ltd., where he continues to develop his innovative techniques. His work has garnered attention for its potential applications in various biotechnological fields.

Collaborations

He has collaborated with notable colleagues, including Kyeong-Eun Jung and Moon Hee Kim, to further advance research in nucleotide chemistry.

Conclusion

Alexei Kayushin's contributions to the preparation of nucleotide oligomers represent a significant advancement in the field. His innovative methods promise to improve the efficiency and purity of nucleotide synthesis, paving the way for future developments in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…